EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Phagocytosis activity is retained by JMML macrophages and increased by CD47 inhibition

Jun Wang iD, Jovana Rajak iD, Hui Xiao, Naile Koleci iD, Anna Lena Stippel iD, Ke Meng iD, Niels Anton Wehner, Sheila Bohler iD, Riccardo Masetti iD, Charlotte Niemeyer iD, Bertram Bengsch iD, Miriam Erlacher iD

British Journal of Haematology · 09.11.2026

DOI: 10.1111/bjh.70871 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 09.11.2026. Verfasst von Jun Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, University Medical Center Freiburg, Faculty of Medic…. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DFG-funded Collaborative Research Centre (CRC/SFB), German Federal Ministry of Education and Research (BMBF), Berlin, Deutsche Forschungsgemeinschaft (DFG, German Research Foundation).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Juvenile myelomonocytic leukaemia (JMML) is a childhood myeloid malignancy driven by RAS (rat sarcoma viral oncogene homolog) pathway mutations, characterized by myeloid cell accumulation and organ infiltration. We investigated how clonal macrophage polarization, phagocytic function and CD47 (cluster of differentiation 47) expression contribute to immune dysregulation. Human PTPN11 (protein tyrosine phosphatase non‐receptor type 11) ‐mutated JMML spleens exhibited higher M1‐like macrophage levels than KRAS (KRAS proto‐oncogene, GTPase)‐mutated cases or controls. Both human JMML macrophages and murine cells from Mx‐Cre;Ptpn11 D61Y/+ mice retained phagocytic activity, with M1‐like cells being the most active. CD47, a ‘don't eat me’ signal, was upregulated in human and murine JMML cells; its blockade enhanced in vitro phagocytosis. In a patient‐derived xenograft model, the CD47 inhibitor magrolimab reduced leukaemia burden in the spleen but not the bone marrow. No synergy was observed between magrolimab and azacitidine. These findings demonstrate that clonal JMML macrophages retain phagocytic activity and contribute to an inflammatory phenotype. While CD47 blockade shows limited therapeutic potential, this study clarifies the interplay between macrophage polarization, immune evasion and inflammation, providing a basis for future JMML strategies.

Schlagwörter

Stichwörter der Autor:innen

CD47JMMLhaematologymacrophagesphagocytosis

Autor:innen und Institutionen

  • Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Baden-Wuerttemberg, Germany.
  • Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Baden-Wuerttemberg, Germany.
  • Faculty of Biology, University of Freiburg, Freiburg, Baden-Wuerttemberg, Germany.
  • Spemann Graduate School of Biology and Medicine (SGBM), University of Freiburg, Freiburg, Baden-Wuerttemberg, Germany.
  • Department of Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases, Medical Center-University of Freiburg, Freiburg, Baden-Wuerttemberg, Germany.
  • Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Emilia-Romagna, Italy.

ORCID-Profile: Jun Wang, Jovana Rajak, Naile Koleci, Anna Lena Stippel, Ke Meng, Sheila Bohler, Riccardo Masetti, Charlotte Niemeyer, Bertram Bengsch, Miriam Erlacher

Förderung

  • DFG-funded Collaborative Research Centre (CRC/SFB)
  • German Federal Ministry of Education and Research (BMBF), Berlin
  • Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
  • José Carreras Leukämie-Stiftung
  • China Scholarship Council (CSC) Scholarship
  • University of Freiburg

Zitieren

APA

Wang, J., Rajak, J., Xiao, H., Koleci, N., Stippel, A. L., Meng, K., Wehner, N. A., Bohler, S., Masetti, R., Niemeyer, C., Bengsch, B., & Erlacher, M. (2026). Phagocytosis activity is retained by JMML macrophages and increased by CD47 inhibition. British Journal of Haematology. https://doi.org/10.1111/bjh.70871

Vancouver

Wang J, Rajak J, Xiao H, Koleci N, Stippel AL, Meng K, et al. Phagocytosis activity is retained by JMML macrophages and increased by CD47 inhibition. British Journal of Haematology. 2026. doi:10.1111/bjh.70871

BibTeX
@article{Wang2026,
  author = {Wang, Jun and Rajak, Jovana and Xiao, Hui and Koleci, Naile and Stippel, Anna Lena and Meng, Ke and Wehner, Niels Anton and Bohler, Sheila and Masetti, Riccardo and Niemeyer, Charlotte and Bengsch, Bertram and Erlacher, Miriam},
  title = {Phagocytosis activity is retained by JMML macrophages and increased by CD47 inhibition},
  journal = {British Journal of Haematology},
  year = {2026},
  doi = {10.1111/bjh.70871}
}
Kostenlos starten →